Selected research
Industry Research
Neurocognitive Assessment and Rehabilitation Industry Research Report 2026
Market perspective
The global Neurocognitive Assessment and Rehabilitation market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Neurocognitive Assessment and Rehabilitation market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Neurocognitive Assessment and Rehabilitation market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Neurocognitive Assessment and Rehabilitation market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Neurocognitive Assessment and Rehabilitation include Cambridge Cognition Holdings plc, Cognifit, Inc., Cogstate Ltd., Lumos Labs, Inc. (Lumosity), CNS Vital Signs, LLC, Posit Science Corporation, BrainCheck, Inc., Constant Therapy Health and NeuronUP SL and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Neurocognitive Assessment and Rehabilitation market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Neurocognitive Assessment and Rehabilitation.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Neurocognitive Assessment and Rehabilitation Market by Company
Cambridge Cognition Holdings plc
Cognifit, Inc.
Cogstate Ltd.
Lumos Labs, Inc. (Lumosity)
CNS Vital Signs, LLC
Posit Science Corporation
BrainCheck, Inc.
Constant Therapy Health
NeuronUP SL
SCHUHFRIED GmbH
Neurocognitive Assessment and Rehabilitation Segment by Type
Neurorehabilitation Therapy
Neurocognitive Assessment Testing
Neurocognitive Assessment and Rehabilitation Segment by Application
Rehab Centers
Hospital & Clinics
Homecare Settings
Physiotherapy Centers
Neurocognitive Assessment and Rehabilitation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurocognitive Assessment and Rehabilitation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurocognitive Assessment and Rehabilitation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurocognitive Assessment and Rehabilitation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Neurocognitive Assessment and Rehabilitation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Neurorehabilitation Therapy
- Neurocognitive Assessment Testing
Applications
- Rehab Centers
- Hospital & Clinics
- Homecare Settings
- Physiotherapy Centers
Companies covered
- Cambridge Cognition Holdings plc
- Cognifit, Inc.
- Cogstate Ltd.
- Lumos Labs, Inc. (Lumosity)
- CNS Vital Signs, LLC
- Posit Science Corporation
- BrainCheck, Inc.
- Constant Therapy Health
- NeuronUP SL
- SCHUHFRIED GmbH
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Neurocognitive Assessment and Rehabilitation by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Neurorehabilitation Therapy
- 2.2.3 Neurocognitive Assessment Testing
- 2.3 Neurocognitive Assessment and Rehabilitation by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Rehab Centers
- 2.3.3 Hospital & Clinics
- 2.3.4 Homecare Settings
- 2.3.5 Physiotherapy Centers
- 2.4 Assumptions and Limitations
3 Neurocognitive Assessment and Rehabilitation Breakdown Data by Type
- 3.1 Global Neurocognitive Assessment and Rehabilitation Historic Market Size by Type (2021-2026)
- 3.2 Global Neurocognitive Assessment and Rehabilitation Forecasted Market Size by Type (2027-2032)
4 Neurocognitive Assessment and Rehabilitation Breakdown Data by Application
- 4.1 Global Neurocognitive Assessment and Rehabilitation Historic Market Size by Application (2021-2026)
- 4.2 Global Neurocognitive Assessment and Rehabilitation Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Neurocognitive Assessment and Rehabilitation Market Perspective (2021-2032)
- 5.2 Global Neurocognitive Assessment and Rehabilitation Growth Trends by Region
- 5.2.1 Global Neurocognitive Assessment and Rehabilitation Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Neurocognitive Assessment and Rehabilitation Historic Market Size by Region (2021-2026)
- 5.2.3 Neurocognitive Assessment and Rehabilitation Forecasted Market Size by Region (2027-2032)
- 5.3 Neurocognitive Assessment and Rehabilitation Market Dynamics
- 5.3.1 Neurocognitive Assessment and Rehabilitation Industry Trends
- 5.3.2 Neurocognitive Assessment and Rehabilitation Market Drivers
- 5.3.3 Neurocognitive Assessment and Rehabilitation Market Challenges
- 5.3.4 Neurocognitive Assessment and Rehabilitation Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Neurocognitive Assessment and Rehabilitation Players by Revenue
- 6.1.1 Global Top Neurocognitive Assessment and Rehabilitation Players by Revenue (2021-2026)
- 6.1.2 Global Neurocognitive Assessment and Rehabilitation Revenue Market Share by Players (2021-2026)
- 6.2 Global Neurocognitive Assessment and Rehabilitation Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Neurocognitive Assessment and Rehabilitation Head Office and Area Served
- 6.4 Global Neurocognitive Assessment and Rehabilitation Players, Product Type & Application
- 6.5 Global Neurocognitive Assessment and Rehabilitation Manufacturers Established Date
- 6.6 Global Neurocognitive Assessment and Rehabilitation Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Neurocognitive Assessment and Rehabilitation Market Size (2021-2032)
- 7.2 North America Neurocognitive Assessment and Rehabilitation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Neurocognitive Assessment and Rehabilitation Market Size by Country (2021-2026)
- 7.4 North America Neurocognitive Assessment and Rehabilitation Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Neurocognitive Assessment and Rehabilitation Market Size (2021-2032)
- 8.2 Europe Neurocognitive Assessment and Rehabilitation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Neurocognitive Assessment and Rehabilitation Market Size by Country (2021-2026)
- 8.4 Europe Neurocognitive Assessment and Rehabilitation Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Neurocognitive Assessment and Rehabilitation Market Size (2021-2032)
- 9.2 Asia-Pacific Neurocognitive Assessment and Rehabilitation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Neurocognitive Assessment and Rehabilitation Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Neurocognitive Assessment and Rehabilitation Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Neurocognitive Assessment and Rehabilitation Market Size (2021-2032)
- 10.2 South America Neurocognitive Assessment and Rehabilitation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Neurocognitive Assessment and Rehabilitation Market Size by Country (2021-2026)
- 10.4 South America Neurocognitive Assessment and Rehabilitation Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Neurocognitive Assessment and Rehabilitation Market Size (2021-2032)
- 11.2 Middle East & Africa Neurocognitive Assessment and Rehabilitation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Neurocognitive Assessment and Rehabilitation Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Neurocognitive Assessment and Rehabilitation Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Cambridge Cognition Holdings plc
- 12.1.1 Cambridge Cognition Holdings plc Company Information
- 12.1.2 Cambridge Cognition Holdings plc Business Overview
- 12.1.3 Cambridge Cognition Holdings plc Revenue in Neurocognitive Assessment and Rehabilitation Business (2021-2026)
- 12.1.4 Cambridge Cognition Holdings plc Neurocognitive Assessment and Rehabilitation Product Portfolio
- 12.1.5 Cambridge Cognition Holdings plc Recent Developments
- 12.2 Cognifit, Inc.
- 12.2.1 Cognifit, Inc. Company Information
- 12.2.2 Cognifit, Inc. Business Overview
- 12.2.3 Cognifit, Inc. Revenue in Neurocognitive Assessment and Rehabilitation Business (2021-2026)
- 12.2.4 Cognifit, Inc. Neurocognitive Assessment and Rehabilitation Product Portfolio
- 12.2.5 Cognifit, Inc. Recent Developments
- 12.3 Cogstate Ltd.
- 12.3.1 Cogstate Ltd. Company Information
- 12.3.2 Cogstate Ltd. Business Overview
- 12.3.3 Cogstate Ltd. Revenue in Neurocognitive Assessment and Rehabilitation Business (2021-2026)
- 12.3.4 Cogstate Ltd. Neurocognitive Assessment and Rehabilitation Product Portfolio
- 12.3.5 Cogstate Ltd. Recent Developments
- 12.4 Lumos Labs, Inc. (Lumosity)
- 12.4.1 Lumos Labs, Inc. (Lumosity) Company Information
- 12.4.2 Lumos Labs, Inc. (Lumosity) Business Overview
- 12.4.3 Lumos Labs, Inc. (Lumosity) Revenue in Neurocognitive Assessment and Rehabilitation Business (2021-2026)
- 12.4.4 Lumos Labs, Inc. (Lumosity) Neurocognitive Assessment and Rehabilitation Product Portfolio
- 12.4.5 Lumos Labs, Inc. (Lumosity) Recent Developments
- 12.5 CNS Vital Signs, LLC
- 12.5.1 CNS Vital Signs, LLC Company Information
- 12.5.2 CNS Vital Signs, LLC Business Overview
- 12.5.3 CNS Vital Signs, LLC Revenue in Neurocognitive Assessment and Rehabilitation Business (2021-2026)
- 12.5.4 CNS Vital Signs, LLC Neurocognitive Assessment and Rehabilitation Product Portfolio
- 12.5.5 CNS Vital Signs, LLC Recent Developments
- 12.6 Posit Science Corporation
- 12.6.1 Posit Science Corporation Company Information
- 12.6.2 Posit Science Corporation Business Overview
- 12.6.3 Posit Science Corporation Revenue in Neurocognitive Assessment and Rehabilitation Business (2021-2026)
- 12.6.4 Posit Science Corporation Neurocognitive Assessment and Rehabilitation Product Portfolio
- 12.6.5 Posit Science Corporation Recent Developments
- 12.7 BrainCheck, Inc.
- 12.7.1 BrainCheck, Inc. Company Information
- 12.7.2 BrainCheck, Inc. Business Overview
- 12.7.3 BrainCheck, Inc. Revenue in Neurocognitive Assessment and Rehabilitation Business (2021-2026)
- 12.7.4 BrainCheck, Inc. Neurocognitive Assessment and Rehabilitation Product Portfolio
- 12.7.5 BrainCheck, Inc. Recent Developments
- 12.8 Constant Therapy Health
- 12.8.1 Constant Therapy Health Company Information
- 12.8.2 Constant Therapy Health Business Overview
- 12.8.3 Constant Therapy Health Revenue in Neurocognitive Assessment and Rehabilitation Business (2021-2026)
- 12.8.4 Constant Therapy Health Neurocognitive Assessment and Rehabilitation Product Portfolio
- 12.8.5 Constant Therapy Health Recent Developments
- 12.9 NeuronUP SL
- 12.9.1 NeuronUP SL Company Information
- 12.9.2 NeuronUP SL Business Overview
- 12.9.3 NeuronUP SL Revenue in Neurocognitive Assessment and Rehabilitation Business (2021-2026)
- 12.9.4 NeuronUP SL Neurocognitive Assessment and Rehabilitation Product Portfolio
- 12.9.5 NeuronUP SL Recent Developments
- 12.10 SCHUHFRIED GmbH
- 12.10.1 SCHUHFRIED GmbH Company Information
- 12.10.2 SCHUHFRIED GmbH Business Overview
- 12.10.3 SCHUHFRIED GmbH Revenue in Neurocognitive Assessment and Rehabilitation Business (2021-2026)
- 12.10.4 SCHUHFRIED GmbH Neurocognitive Assessment and Rehabilitation Product Portfolio
- 12.10.5 SCHUHFRIED GmbH Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst